Goldman Sachs Group Inc Fusion Pharmaceuticals Inc. Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.9 - $21.32 $253,811 - $684,968	32,128 Added 212.32%	47,260 $1.01 Million
Q4 2023 Feb 13, 2024	BUY	$2.48 - $9.65 $37,527 - $146,023	15,132 New	15,132 $145,000
Q4 2021 Feb 14, 2022	SELL	$4.17 - $7.78 $84,021 - $156,759	-20,149 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$7.83 - $9.41 $157,766 - $189,602	20,149 New	20,149 $160,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.